These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9291162)

  • 1. Immunomodulation and remyelination: two aspects of human polyclonal immunoglobulin treatment in immune mediated neuropathies?
    van Schaik IN; Vermeulen M; Brand A
    Mult Scler; 1997 Apr; 3(2):98-104. PubMed ID: 9291162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulins stimulate cultured Schwann cell maturation and promote their potential to induce axonal outgrowth.
    Tzekova N; Heinen A; Bunk S; Hermann C; Hartung HP; Reipert B; Küry P
    J Neuroinflammation; 2015 May; 12():107. PubMed ID: 26022648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin.
    Ephrem A; Misra N; Hassan G; Dasgupta S; Delignat S; Duong Van Huyen JP; Chamat S; Prost F; Lacroix-Desmazes S; Kavery SV; Kazatchkine MD
    Clin Exp Med; 2005 Dec; 5(4):135-40. PubMed ID: 16362793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination.
    van Engelen BG; Pavelko KD; Rodriguez M
    Mult Scler; 1997 Apr; 3(2):76-9. PubMed ID: 9291157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal IgM influence oligodendrocyte precursor cells in mixed glial cell cultures: implications for remyelination.
    Stangel M; Bernard D
    J Neuroimmunol; 2003 May; 138(1-2):25-30. PubMed ID: 12742649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
    Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
    Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cells are resistant to immunomodulation by 'IVIg-educated' dendritic cells.
    Maddur MS; Hegde P; Sharma M; Kaveri SV; Bayry J
    Autoimmun Rev; 2011 Dec; 11(2):154-6. PubMed ID: 21864723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin in neurological disorders: a mechanistic perspective.
    Misra N; Bayry J; Ephrem A; Dasgupta S; Delignat S; Duong Van Huyen JP; Prost F; Lacroix-Desmazes S; Nicoletti A; Kazatchkine MD; Kaveri SV
    J Neurol; 2005 May; 252 Suppl 1():I1-6. PubMed ID: 15959666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies.
    Comi G; Nemni R; Amadio S; Galardi G; Leocani L
    Mult Scler; 1997 Apr; 3(2):93-7. PubMed ID: 9291161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells.
    Séïté JF; Goutsmedt C; Youinou P; Pers JO; Hillion S
    J Allergy Clin Immunol; 2014 Jan; 133(1):181-8.e1-9. PubMed ID: 24139609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous IgG (IVIG) and subcutaneous IgG (SCIG) preparations have comparable inhibitory effect on T cell activation, which is not dependent on IgG sialylation, monocytes or B cells.
    Issekutz AC; Rowter D; Miescher S; Käsermann F
    Clin Immunol; 2015 Oct; 160(2):123-32. PubMed ID: 25982320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases.
    Stangel M; Toyka KV; Gold R
    Arch Neurol; 1999 Jun; 56(6):661-3. PubMed ID: 10369303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated remyelination: relevance to multiple sclerosis.
    Bieber A; Asakura K; Warrington A; Kaveri SV; Rodriguez M
    Mult Scler; 2000 Oct; 6 Suppl 2():S1-5; discussion S33. PubMed ID: 11188771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of myelin phagocytosis by macrophages/microglia, involvement of target myelin, Fc receptors and activation by intravenous immunoglobulins.
    Kuhlmann T; Wendling U; Nolte C; Zipp F; Maruschak B; Stadelmann C; Siebert H; Brück W
    J Neurosci Res; 2002 Jan; 67(2):185-90. PubMed ID: 11782962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders.
    Imbach P; Lazarus AH; Kühne T
    Vox Sang; 2010 Apr; 98(3 Pt 2):385-94. PubMed ID: 19821958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A shift in encephalitogenic T cell cytokine pattern is associated with suppression of EAE by intravenous immunoglobulins (IVIg).
    Pashov A; Bellon B; Kaveri SV; Kazatchkine MD
    Mult Scler; 1997 Apr; 3(2):153-6. PubMed ID: 9291172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelin regeneration in demyelinating disorders: new developments in biology and clinical pathology.
    Zawadzka M; Franklin RJ
    Curr Opin Neurol; 2007 Jun; 20(3):294-8. PubMed ID: 17495623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of autoimmune responses by intravenous immunoglobulin (IVIg).
    Kaveri S; Prasad N; Vassilev T; Hurez V; Pashov A; Lacroix-Desmazes S; Kazatchkine M
    Mult Scler; 1997 Apr; 3(2):121-8. PubMed ID: 9291165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of action of intravenous immune globulin in immune-mediated diseases.
    Mouthon L; Kaveri SV; Spalter SH; Lacroix-Desmazes S; Lefranc C; Desai R; Kazatchkine MD
    Clin Exp Immunol; 1996 May; 104 Suppl 1():3-9. PubMed ID: 8625540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production.
    Tawfik DS; Cowan KR; Walsh AM; Hamilton WS; Goldman FD
    Pediatr Allergy Immunol; 2012 Feb; 23(1):88-95. PubMed ID: 21265884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.